| Company Name: |
T&W GROUP
|
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
| Products Intro: |
Product Name:1-(alpha-L-Threofuranosyl)thymine
CAS:325683-84-9
Purity:98% Package:按需包装
|
1-(alpha-L-Threofuranosyl)thymine manufacturers
|
| | 1-(alpha-L-Threofuranosyl)thymine Basic information |
| Product Name: | 1-(alpha-L-Threofuranosyl)thymine | | Synonyms: | 1-(alpha-L-Threofuranosyl)thymine;1-(α-L-Threofuranosyl)thymine;1-((2R,3R,4S)-3,4-Dihydroxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione;2,4(1H,3H)-Pyrimidinedione, 5-methyl-1-[(2R,3R,4S)-tetrahydro-3,4-dihydroxy-2-furanyl]- | | CAS: | 325683-84-9 | | MF: | C9H12N2O5 | | MW: | 228.2 | | EINECS: | | | Product Categories: | Nucleosides-L-Threofuranosyl Nucleosides | | Mol File: | 325683-84-9.mol |  |
| | 1-(alpha-L-Threofuranosyl)thymine Chemical Properties |
| density | 1.571±0.06 g/cm3(Predicted) | | pka | 9.55±0.10(Predicted) |
| | 1-(alpha-L-Threofuranosyl)thymine Usage And Synthesis |
| Uses | 1-(alpha-L-Threofuranosyl)thymine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 1-(alpha-L-Threofuranosyl)thymine Preparation Products And Raw materials |
|